Neovasculgen® for foot ulcer

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Feb 2025: Trial started, NCT07391319
  2. 5 Feb 2026: Trial registered, NCT07391319

The trials

NCT07391319: The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial

State
Under way
Phase
Phase 3
People
144 planned
Started
11 Feb 2025
Primary completion
31 Mar 2027
Arms
The investigational therapy group (Neovasculgen)
Results
None posted
  1. 11 Feb 2025: Trial started
  2. 5 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.